Cargando…

CKAP4 and mutant p53 cooperatively abrogate cell cycle checkpoint to induce genotoxic resistance in ovarian cancer

Detalles Bibliográficos
Autores principales:	Huang, Canhua, Zhao, Wei, Hao, Qian, Chen, Jianchun, Wu, Lisha, Yang, Wenqing, Lu, Hua, Zhang, Yu, Zhou, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter to the Journal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659766/ https://www.ncbi.nlm.nih.gov/pubmed/37983936 http://dx.doi.org/10.1002/ctm2.1476

Ejemplares similares

BCL7C suppresses ovarian cancer growth by inactivating mutant p53
por: Huang, Canhua, et al.
Publicado: (2020)

Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53
por: Chen, Yajie, et al.
Publicado: (2019)

Cell cycle control, checkpoint mechanisms, and genotoxic stress.
por: Shackelford, R E, et al.
Publicado: (1999)

Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor
por: Massey, Andrew J., et al.
Publicado: (2010)

CKAP2L Promotes Esophageal Squamous Cell Carcinoma Progression and Drug-Resistance by Modulating Cell Cycle
por: Chen, Wenhu, et al.
Publicado: (2022)

DNA breakage and cell cycle checkpoint abrogation induced by a therapeutic thiopurine and UVA radiation
por: Brem, Reto, et al.
Publicado: (2010)

KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer
por: Yao, Litong, et al.
Publicado: (2023)

G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
por: Bucher, N, et al.
Publicado: (2008)

Cyclic adenosine monophosphate potentiates immune checkpoint blockade therapy in acute myeloid leukemia
por: Mao, Ping, et al.
Publicado: (2023)

Modelling how initiating and transforming oncogenes cooperate to produce a leukaemic cell state
por: Richardson, Simon E.
Publicado: (2013)

CKAP2 Ensures Chromosomal Stability by Maintaining the Integrity of Microtubule Nucleation Sites
por: Case, Chanelle M., et al.
Publicado: (2013)

CKAP2L, as an Independent Risk Factor, Closely Related to the Prognosis of Glioma
por: Zhu, Li, et al.
Publicado: (2021)

Novel variants identified in CKAP2L in two siblings with Filippi syndrome
por: Patrick, Ryan J., et al.
Publicado: (2022)

RNA-Binding Profiles of CKAP4 as an RNA-Binding Protein in Myocardial Tissues
por: Zhu, Hong, et al.
Publicado: (2021)

The mitotic spindle protein CKAP2 potently increases formation and stability of microtubules
por: McAlear, Thomas S, et al.
Publicado: (2022)

CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma
por: Zhang, Sen, et al.
Publicado: (2022)

DKK1‐CKAP4 signal axis promotes hepatocellular carcinoma aggressiveness
por: Iguchi, Kosuke, et al.
Publicado: (2023)

CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer
por: Nagoya, Akihiro, et al.
Publicado: (2023)

CKAP4 Antibody-Conjugated Si Quantum Dot Micelles for Targeted Imaging of Lung Cancer
por: Huang, Xin, et al.
Publicado: (2021)

A chlorophyll-protein complex lacking in photosystem I mutants of Chlamydomonas reinhardtii
por: Chua, N. H., et al.
Publicado: (1975)

Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
por: Yan, Junya, et al.
Publicado: (2023)

Knockdown of CKAP2 Inhibits Proliferation, Migration, and Aggregate Formation in Aggressive Breast Cancer
por: dos Santos, Alexsandro, et al.
Publicado: (2022)

Therapeutic gene silencing of CKAP5 leads to lethality in genetically unstable cancer cells
por: Chatterjee, Sushmita, et al.
Publicado: (2023)

Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function
por: Palanikumar, L., et al.
Publicado: (2021)

Ubiquitin ligase DTX3 empowers mutant p53 to promote ovarian cancer development
por: Wang, Shanshan, et al.
Publicado: (2020)

Predictive value of DOT1L mutations for clinical outcomes in non‐small‐cell lung cancer patients receiving immune checkpoint inhibitor therapy
por: Guo, Tianxing, et al.
Publicado: (2023)

MicroRNA-671-3p promotes proliferation and migration of glioma cells via targeting CKAP4
por: Lu, Gui-Feng, et al.
Publicado: (2018)

Chromatin CKAP2, a New Proliferation Marker, as Independent Prognostic Indicator in Breast Cancer
por: Kim, Han-Seong, et al.
Publicado: (2014)

CKAP2 phosphorylation by CDK1/cyclinB1 is crucial for maintaining centrosome integrity
por: Yoo, Bum Ho, et al.
Publicado: (2017)

Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma
por: Liu, Zhi, et al.
Publicado: (2023)

Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice
por: Goh, Amanda M., et al.
Publicado: (2015)

Transcription-independent and -dependent p53-mediated apoptosis in response to genotoxic and non-genotoxic stress
por: Ho, Cheng-Jung, et al.
Publicado: (2019)

Genotoxic stress-activated DNA-PK-p53 cascade and autophagy cooperatively induce ciliogenesis to maintain the DNA damage response
por: Chen, Ting-Yu, et al.
Publicado: (2021)

OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases
por: Ji, Wenbin, et al.
Publicado: (2016)

Up-regulation of CKAP2L expression promotes lung adenocarcinoma invasion and is associated with poor prognosis
por: Xiong, Guosheng, et al.
Publicado: (2019)

Circular RNA ZNF609/CKAP5 mRNA interaction regulates microtubule dynamics and tumorigenicity
por: Rossi, Francesca, et al.
Publicado: (2022)

CKAP2L, a crucial target of miR-326, promotes prostate cancer progression
por: Li, Qi, et al.
Publicado: (2022)

Formin‐like 2 promotes angiogenesis and metastasis of colorectal cancer by regulating the EGFL6/CKAP4/ERK axis
por: He, Guoyang, et al.
Publicado: (2023)

Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient
por: Anchisi, Sandro, et al.
Publicado: (2023)

Mutant p53 in cancer therapy—the barrier or the path
por: Zhou, Xiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e68vfecvfaerkbl7ftbabbtras